$2.06
-0.04 (-1.90%)
Open$2.08
Previous Close$2.10
Day High$2.12
Day Low$2.03
52W High$3.56
52W Low$1.27
Volume—
Avg Volume434.8K
Market Cap90.85M
P/E Ratio—
EPS$-1.88
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+1,968.4% upside
Current
$2.06
$2.06
Target
$42.61
$42.61
$22.54
$42.61 avg
$49.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.49M | 26.17M | 29.17M |
| Net Income | -6,413,122 | -6,638,758 | -7,979,028 |
| Profit Margin | -23.3% | -25.4% | -27.4% |
| EBITDA | -10,041,478 | -10,799,684 | -11,152,703 |
| Free Cash Flow | -6,132,912 | -6,792,749 | -5,207,622 |
| Rev Growth | +12.4% | +6.3% | +17.3% |
| Debt/Equity | 0.29 | 0.25 | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |